{"id":395,"date":"2026-04-12T08:07:07","date_gmt":"2026-04-12T08:07:07","guid":{"rendered":"https:\/\/luciuspharmacy.com\/?post_type=product&#038;p=395"},"modified":"2026-09-30T09:04:12","modified_gmt":"2026-09-30T09:04:12","slug":"lucituca-tucatinib-150-mgx60-tablets","status":"publish","type":"product","link":"https:\/\/luciuspharmacy.com\/zh\/product\/lucituca-tucatinib-150-mgx60-tablets\/","title":{"rendered":"\u56fe\u5361\u66ff\u5c3c"},"content":{"rendered":"<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\"><strong>HIGHLIGHTS OF PRESCRIBING INFORMATION<\/strong><\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\"><strong>These highlights do not include all the information needed to use LuciTuca safely and effectively. See full prescribing information for LuciTuca.<\/strong><\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">&nbsp;<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\"><strong>INDICATIONS AND USAGE<\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">LuciTuca&nbsp;is a kinase inhibitor indicated:<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022&nbsp;in combination with trastuzumab and capecitabine for treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases, who have received one or more prior anti-HER2-based regimens in the metastatic setting.<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022&nbsp;in combination with trastuzumab for the treatment of adult patients with RAS wild-type HER2-positive unresectable or metastatic colorectal cancer that has progressed following treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">&nbsp;<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\"><strong>DOSAGE AND ADMINISTRATION<\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022&nbsp;In patients with unresectable or metastatic colorectal cancer, confirm the presence of HER2 protein overexpression and RAS wild-type in tumor specimens prior to the initiation of&nbsp;LuciTuca.<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022&nbsp;Recommended dosage: 300 mg taken orally twice daily with or without food.&nbsp;<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022&nbsp;For patients with severe hepatic impairment, the recommended dosage is 200 mg orally twice daily.<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">&nbsp;<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\"><strong>DOSAGE FORMS AND STRENGTHS<\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">Tablets:&nbsp;150&nbsp;mg\u00d760 tablets<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">&nbsp;<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\"><strong>CONTRAINDICATIONS<\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">None.<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">&nbsp;<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\"><strong>WARNINGS AND PRECAUTIONS<\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022&nbsp;Diarrhea: Severe diarrhea, including dehydration, acute kidney injury, and death, has been reported. Administer antidiarrheal treatment as clinically&nbsp;indicated. Interrupt dose, then dose reduce, or permanently discontinue&nbsp;<span style=\"text-wrap-mode: wrap;\"><span style=\"color: rgb(88, 88, 88);\">LuciTuca<\/span><\/span>&nbsp;based on severity.<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022&nbsp;Hepatotoxicity: Severe hepatotoxicity has been reported on&nbsp;<span style=\"text-wrap-mode: wrap;\"><span style=\"color: rgb(88, 88, 88);\">LuciTuca<\/span><\/span>. Monitor ALT, AST and bilirubin prior to starting&nbsp;<span style=\"text-wrap-mode: wrap;\"><span style=\"color: rgb(88, 88, 88);\">LuciTuca<\/span><\/span>, every 3 weeks during treatment and as clinically indicated. Interrupt dose, then dose reduce, or permanently discontinue&nbsp;LuciTuca&nbsp;based on severity.<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022&nbsp;Embryo-Fetal Toxicity:&nbsp;<span style=\"text-wrap-mode: wrap;\"><span style=\"color: rgb(88, 88, 88);\">LuciTuca<\/span><\/span>&nbsp;can cause fetal harm. Advise patients of potential risk to a fetus and to use effective contraception.<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">Also, refer to the Full Prescribing Information of trastuzumab and capecitabine for pregnancy and contraception information.<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">&nbsp;<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\"><strong>ADVERSE REACTIONS<\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022 The most common adverse reactions (\u226520%) with&nbsp;<span style=\"color: rgb(88, 88, 88); text-wrap-mode: wrap;\">LuciTuca<\/span>&nbsp;in&nbsp;combination with trastuzumab and capecitabine in patients with metastatic breast cancer are diarrhea, palmar-plantar erythrodysesthesia, nausea, hepatotoxicity, vomiting, stomatitis, decreased appetite, anemia, and rash.<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022 The most common adverse reactions (\u226520%) with&nbsp;<span style=\"color: rgb(88, 88, 88); text-wrap-mode: wrap;\">LuciTuca<\/span>&nbsp;in&nbsp;combination with trastuzumab in patients with unresectable or metastatic colorectal cancer are diarrhea, fatigue, rash, nausea, abdominal pain, infusion related reactions, and pyrexia.<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">&nbsp;<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\"><strong>DRUG INTERACTIONS<\/strong><strong><\/strong><\/span><\/p>\n<p style=\"margin-top: 2px; margin-right: 27px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022&nbsp;Strong CYP3A Inducers or Moderate CYP2C8 Inducers: Avoid concomitant use.<\/span><\/p>\n<p style=\"margin-top: 2px; margin-right: 27px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022&nbsp;Strong CYP2C8 Inhibitors: Avoid concomitant use; reduce&nbsp;<span style=\"color: rgb(88, 88, 88); text-wrap-mode: wrap;\">LuciTuca<\/span>&nbsp;dose if concomitant use cannot be avoided.<\/span><\/p>\n<p style=\"margin-top: 2px; margin-right: 27px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022&nbsp;CYP3A Substrates: Avoid concomitant use with CYP3A substrates, where minimal concentration changes may lead to serious or life-threatening toxicities.<\/span><\/p>\n<p style=\"margin-top: 2px; margin-right: 27px;\"><span style=\"color: rgb(89, 89, 89);\">\u2022&nbsp;P-gp Substrates: Consider reducing the dose of P-gp substrates, where minimal concentration changes may lead to serious or life-threatening toxicities.<\/span><\/p>\n<p style=\"margin-top: 2px; margin-right: 27px;\"><span style=\"color: rgb(89, 89, 89);\">&nbsp;<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\"><strong>USE IN SPECIFIC POPULATIONS<\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">Lactation: Advise not to breastfeed.<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">&nbsp;<\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\"><strong>Storage<\/strong><strong><\/strong><\/span><\/p>\n<p style=\"line-height: 20px;\"><span style=\"color: rgb(89, 89, 89);\">Store at 20\u2103&nbsp;to 25\u2103&nbsp;(68\u2109&nbsp;to 77\u2109), excursions permitted between 15\u2103&nbsp;and 30\u2103&nbsp;(59\u2109&nbsp;and 86\u2109) [see USP Controlled Room Temperature]. Protect from moisture.&nbsp;<\/span><\/p>\n<p><\/p>\n<p><\/p>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>LuciTuca contains tucatinib and is supplied as 150 mg tablets in a pack of 60. Please review the full product information with your prescriber. A valid prescription and identity verification are required before ordering.<\/p>","protected":false},"featured_media":1801,"comment_status":"open","ping_status":"closed","template":"","meta":{"advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false,"jetpack_seo_schema_type":""},"product_brand":[],"product_cat":[20],"product_tag":[],"class_list":["post-395","product","type-product","status-publish","has-post-thumbnail","product_cat-breast-cancer","first","instock","shipping-taxable","purchasable","product-type-simple"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/luciuspharmacy.com\/zh\/wp-json\/wp\/v2\/product\/395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/luciuspharmacy.com\/zh\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/luciuspharmacy.com\/zh\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/luciuspharmacy.com\/zh\/wp-json\/wp\/v2\/comments?post=395"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/luciuspharmacy.com\/zh\/wp-json\/wp\/v2\/media\/1801"}],"wp:attachment":[{"href":"https:\/\/luciuspharmacy.com\/zh\/wp-json\/wp\/v2\/media?parent=395"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/luciuspharmacy.com\/zh\/wp-json\/wp\/v2\/product_brand?post=395"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/luciuspharmacy.com\/zh\/wp-json\/wp\/v2\/product_cat?post=395"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/luciuspharmacy.com\/zh\/wp-json\/wp\/v2\/product_tag?post=395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}